心胸血管外科（兒科）
止血的管理和優化
抗纖溶藥物
Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. （開啟新視窗）
來源: Anesth Analg 2006;102(3):731-7.
檢索: PubMed 16492820
DOI碼: 10.1213/01.ane.0000194954.64293.61
A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. （開啟新視窗）
來源: Pediatr Surg Int 2012;28(11):1059-69.
檢索: PubMed 22940882
DOI碼: 10.1007/s00383-012-3167-6
Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. （開啟新視窗）
來源: Br J Anaesth 2012;108(5):830-7.
檢索: PubMed 22362670
DOI碼: 10.1093/bja/aes002
Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. （開啟新視窗）
來源: J Cardiothorac Vasc Anesth 2004;18(2):141-3.
檢索: PubMed 15073700
Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. （開啟新視窗）
來源: Ann Thorac Surg 2000;70(4):1308-12.
檢索: PubMed 11081890
The Bayer 022 compassionate-use pediatric study. （開啟新視窗）
來源: Ann Thorac Surg 1998;65(6 Suppl):S31-3.
檢索: PubMed 9647135
Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. （開啟新視窗）
來源: J Thorac Cardiovasc Surg 2012;143(5):1069-76.
檢索: PubMed 22075061
DOI碼: 10.1016/j.jtcvs.2011.08.051
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] （開啟新視窗）
來源: Can J Anaesth 2006;53(6 Suppl):S59-67.
檢索: PubMed 16766791
Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. （開啟新視窗）
來源: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.
檢索: PubMed 24637029
DOI碼: 10.1177/0218492314527991
The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. （開啟新視窗）
來源: PLoS One 2015;10(5):e0126514.
檢索: PubMed 25954976
DOI碼: 10.1371/journal.pone.0126514
Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. （開啟新視窗）
來源: Int J Clin Exp Pathol 2015;8(7):7978-87.
檢索: PubMed 26339364
Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. （開啟新視窗）
來源: Eur J Cardiothorac Surg 2011;39(6):892-7.
檢索: PubMed 21115357
DOI碼: 10.1016/j.ejcts.2010.09.041
Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. （開啟新視窗）
來源: Br J Anaesth 2013;110(4):615-21.
檢索: PubMed 23213034
DOI碼: 10.1093/bja/aes430
Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. （開啟新視窗）
來源: Ann Thorac Surg 1998;66(2):535-40; discussion 541.
檢索: PubMed 9725399
Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. （開啟新視窗）
來源: Ann Card Anaesth 2015;18(1):23-6.
檢索: PubMed 25566706
DOI碼: 10.4103/0971-9784.148316
Comparative analysis of antifibrinolytic medications in pediatric heart surgery. （開啟新視窗）
來源: J Thorac Cardiovasc Surg 2012;143(3):550-7.
檢索: PubMed 22264414
DOI碼: 10.1016/j.jtcvs.2011.06.048
The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. （開啟新視窗）
來源: Anesth Analg 1997;84(5):990-6.
檢索: PubMed 9141920
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. （開啟新視窗）
來源: Eur J Anaesthesiol 2015;32(12):844-50.
檢索: PubMed 26258658
DOI碼: 10.1097/EJA.0000000000000316
Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. （開啟新視窗）
來源: J Cardiothorac Vasc Anesth 2013;27(1):23-9.
檢索: PubMed 22995453
DOI碼: 10.1053/j.jvca.2012.07.001
Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. （開啟新視窗）
來源: Ann Card Anaesth 2010;13(2):110-5.
檢索: PubMed 20442540
DOI碼: 10.4103/0971-9784.62935
Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. （開啟新視窗）
來源: Anesthesiology 2015;122(4):746-58.
檢索: PubMed 25585004
DOI碼: 10.1097/ALN.0000000000000570
Efficacy and safety of aprotinin in neonatal congenital heart operations. （開啟新視窗）
來源: Ann Thorac Surg 2011;92(3):958-63.
檢索: PubMed 21871283
DOI碼: 10.1016/j.athoracsur.2011.04.094
The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. （開啟新視窗）
來源: J Thorac Cardiovasc Surg 1996;111(5):982-7.
檢索: PubMed 8622323
重組活化凝血因子VII（rFVIIa）
Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. （開啟新視窗）
來源: Ann Thorac Surg 2007;84(1):161-8.
檢索: PubMed 17588404
DOI碼: 10.1016/j.athoracsur.2007.02.051
Pediatric off-label use of recombinant factor VIIa. （開啟新視窗）
來源: Pediatrics 2009;123(3):1066-72.
檢索: PubMed 19255041
DOI碼: 10.1542/peds.2008-1685
Factor VII for excessive bleeding following congenital heart disease surgery. （開啟新視窗）
來源: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.
檢索: PubMed 22499956
DOI碼: 10.1177/0218492311433614
Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. （開啟新視窗）
來源: Paediatr Anaesth 2009;19(4):364-70.
檢索: PubMed 19143947
DOI碼: 10.1111/j.1460-9592.2008.02905.x
Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. （開啟新視窗）
來源: Anesth Analg 2012;115(2):364-78.
檢索: PubMed 22652310
DOI碼: 10.1213/ANE.0b013e31825aff10
Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? （開啟新視窗）
來源: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.
檢索: PubMed 22811512
DOI碼: 10.1093/icvts/ivs309
Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. （開啟新視窗）
來源: J Cardiothorac Vasc Anesth 2012;26(4):651-3.
檢索: PubMed 21924639
DOI碼: 10.1053/j.jvca.2011.07.012
Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. （開啟新視窗）
來源: J Cardiothorac Vasc Anesth 2011;25(6):987-94.
檢索: PubMed 21835642
DOI碼: 10.1053/j.jvca.2011.05.012
Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. （開啟新視窗）
來源: J Clin Anesth 2014;26(3):204-11.
檢索: PubMed 24809789
DOI碼: 10.1016/j.jclinane.2013.10.015
Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. （開啟新視窗）
來源: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.
檢索: PubMed 22371937
DOI碼: 10.1177/0218492311432584
Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. （開啟新視窗）
來源: Pediatr Crit Care Med 2003;4(1):49-51.
檢索: PubMed 12656542
DOI碼: 10.1097/01.PCC.0000031472.55687.4E
Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. （開啟新視窗）
來源: J Intensive Care Med 2004;19(5):270-3.
檢索: PubMed 15358945
DOI碼: 10.1177/0885066604267783
Recombinant activated factor VII in cardiac surgery: a systematic review. （開啟新視窗）
來源: Ann Thorac Surg 2007;83(2):707-14.
檢索: PubMed 17258029
DOI碼: 10.1016/j.athoracsur.2006.10.033
Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? （開啟新視窗）
來源: Pediatr Crit Care Med 2009;10(5):572-82.
檢索: PubMed 19451849
DOI碼: 10.1097/PCC.0b013e3181a642d5
Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. （開啟新視窗）
來源: Pediatr Cardiol 2013;34(1):119-24.
檢索: PubMed 22760694
DOI碼: 10.1007/s00246-012-0398-1
Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. （開啟新視窗）
來源: Pediatr Hematol Oncol 2008;25(4):301-11.
檢索: PubMed 18484474
DOI碼: 10.1080/08880010802016904
凝血因子濃縮劑
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. （開啟新視窗）
來源: Artif Organs 2010;34(11):955-60.
檢索: PubMed 21092037
DOI碼: 10.1111/j.1525-1594.2010.01148.x
Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. （開啟新視窗）
來源: Eur J Anaesthesiol 2014;31(6):317-26.
檢索: PubMed 24503704
DOI碼: 10.1097/EJA.0000000000000043
Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. （開啟新視窗）
來源: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.
檢索: PubMed 27493092
DOI碼: 10.1053/j.jvca.2016.04.015
Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. （開啟新視窗）
來源: J Thorac Cardiovasc Surg 2014;148(4):1647-55.
檢索: PubMed 24951020
DOI碼: 10.1016/j.jtcvs.2014.04.029
Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. （開啟新視窗）
來源: Vox Sang 2016;110(3):253-7.
檢索: PubMed 26509839
DOI碼: 10.1111/vox.12353
去氨加壓素
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] （開啟新視窗）
來源: Can J Anaesth 2006;53(6 Suppl):S59-67.
檢索: PubMed 16766791
Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. （開啟新視窗）
來源: AANA J 2007;75(4):261-4.
檢索: PubMed 17711156
局部止血藥
A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. （開啟新視窗）
來源: Ann Surg 2010;251(2):217-28.
檢索: PubMed 20010084
DOI碼: 10.1097/SLA.0b013e3181c3bcca
Resternotomy in pediatric cardiac surgery: CoSeal initial experience. （開啟新視窗）
來源: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.
檢索: PubMed 17669759
DOI碼: 10.1510/icvts.2006.141531
利用血液粘彈性檢測辨別外科性出血或凝血病出血
Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. （開啟新視窗）
來源: Ann Card Anaesth 2012;15(1):26-31.
檢索: PubMed 22234018
DOI碼: 10.4103/0971-9784.91477
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. （開啟新視窗）
來源: Artif Organs 2010;34(11):955-60.
檢索: PubMed 21092037
DOI碼: 10.1111/j.1525-1594.2010.01148.x
Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. （開啟新視窗）
來源: Br J Anaesth 2015;114(1):91-102.
檢索: PubMed 25303988
DOI碼: 10.1093/bja/aeu339